ZINZINO |
End-of-day quote
Other stock markets
|
||
| - SEK | - |
|
| May. 13 | Zinzino Buys Assets in Luxembourg-based Direct Sales Group Xelliss | MT |
| May. 12 | Zinzino AB (OM:ZZ B) acquired Assets from Xelliss S.a. for approximately ?10 million. | CI |
| Sales 2024 * | 2.06B 194M | Sales 2025 * | 2.25B 212M | Capitalization | 2.59B 245M |
|---|---|---|---|---|---|
| Net income 2024 * | 186M 17.56M | Net income 2025 * | 212M 20.02M | EV / Sales 2024 * | 1.43 x |
| Net Debt 2024 * | 355M 33.52M | Net Debt 2025 * | 459M 43.34M | EV / Sales 2025 * | 1.36 x |
| P/E ratio 2024 * |
14.6
x | P/E ratio 2025 * |
12.7
x | Employees | - |
| Yield 2024 * |
2.65% | Yield 2025 * |
2.31% | Free-Float | 53.52% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 11-12-31 | |
Fredrik Nielsen
DFI | Director of Finance/CFO | 47 | 08-12-31 |
| Chief Tech/Sci/R&D Officer | 48 | 17-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 06-12-31 | |
Anna Maria Frick
BRD | Director/Board Member | 56 | - |
| Director/Board Member | 52 | - |
Zinzino AB is a Sweden-based global Company engaged in selling dietary supplements, skin care and lifestyle products. The Company specializes in biomarker-based, personalized nutrition and health tech. The Companyâs test-based, scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino AB owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The Companyâs headquarter is in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong, Malaysia and India.
Sector
Other Specialty Retailers
Calendar
2024-08-29
- Q2 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 843M | |
| +3.15% | 704M | |
| +31.19% | 479M | |
| 0.00% | 135M | |
| +113.04% | 59.39M |
